Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial

Peer Review reports

Original Submission
29 Aug 2017	Submitted	Original manuscript
9 Apr 2018	Author responded	Author comments - Xinxin Zhang
Resubmission - Version 2
9 Apr 2018	Submitted	Manuscript version 2
1 May 2018	Author responded	Author comments - Xinxin Zhang
Resubmission - Version 3
1 May 2018	Submitted	Manuscript version 3
15 May 2018	Reviewed	Reviewer Report - James Wason
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
17 Jul 2018	Editorially accepted
5 Sep 2018	Article published	10.1186/s13063-018-2812-3

Back to article page